UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$288M |
| 2 |
iShares US Treasury Bond ETF
GOVT
|
+$215M |
| 3 |
Tractor Supply
TSCO
|
+$157M |
| 4 |
Johnson & Johnson
JNJ
|
+$153M |
| 5 |
PayPal
PYPL
|
+$135M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$339M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$244M |
| 3 |
PX
Praxair Inc
PX
|
+$218M |
| 4 |
Meta Platforms (Facebook)
META
|
+$182M |
| 5 |
Adobe
ADBE
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.47% |
| 2 | Healthcare | 14.9% |
| 3 | Financials | 14.08% |
| 4 | Consumer Discretionary | 11.32% |
| 5 | Communication Services | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Cimpress
CMPR
$2.31B
| $1.68M | ﹤0.01% |
16,240
+720
| +5% | +$83.6K |
|
|
FMBI
1477
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $1.67M | ﹤0.01% |
84,539
+13,302
| +19% | +$306K |
|
|
JBTM
1478
JBT Marel
JBTM
$6.39B
| $1.67M | ﹤0.01% |
23,209
+2,908
| +14% | +$258K |
|
|
CSR
1479
Centerspace
CSR
$952M
| $1.67M | ﹤0.01% |
33,963
-705
| -2% | -$37.6K |
|
|
SEM
1480
DELISTED
Select Medical
SEM
| $1.67M | ﹤0.01% |
201,498
+17,026
| +9% | +$163K |
|
1481
Myriad Genetics
MYGN
$312M
| $1.66M | ﹤0.01% |
57,103
+8,616
| +18% | +$310K |
|
1482
Capitol Federal Financial
CFFN
$1.1B
| $1.66M | ﹤0.01% |
129,969
+5,551
| +4% | +$71.3K |
|
|
VNE
1483
DELISTED
Veoneer, Inc.
VNE
| $1.66M | ﹤0.01% |
70,388
-12,734
| -15% | -$448K |
|
|
SYNH
1484
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $1.65M | ﹤0.01% |
41,963
+1,745
| +4% | +$81.1K |
|
|
AVNS
1485
DELISTED
Avanos Medical
AVNS
| $1.65M | ﹤0.01% |
36,860
+36,844
| +230,275% | +$1.93M |
|
1486
CVB Financial
CVBF
$3.99B
| $1.64M | ﹤0.01% |
81,194
+72
| +0.1% | +$1.56K |
|
|
IRBT
1487
DELISTED
iRobot
IRBT
| $1.64M | ﹤0.01% |
19,555
+1,992
| +11% | +$181K |
|
|
ALX
1488
Alexander's
ALX
$1.41B
| $1.64M | ﹤0.01% |
5,367
-2
| -0% | -$638 |
|
|
PDCO
1489
DELISTED
Patterson Companies, Inc.
PDCO
| $1.63M | ﹤0.01% |
82,994
+4,621
| +6% | +$108K |
|
|
GBT
1490
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $1.63M | ﹤0.01% |
39,660
+8,014
| +25% | +$300K |
|
|
AJRD
1491
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $1.63M | ﹤0.01% |
46,187
| – | – |
|
1492
WesBanco
WSBC
$4B
| $1.63M | ﹤0.01% |
44,320
+2,328
| +6% | +$95K |
|
1493
Sanmina
SANM
$10.9B
| $1.62M | ﹤0.01% |
67,530
+3,072
| +5% | +$77.3K |
|
1494
SiteOne Landscape Supply
SITE
$4.53B
| $1.62M | ﹤0.01% |
29,387
+1,552
| +6% | +$97.3K |
|
|
PDCE
1495
DELISTED
PDC Energy, Inc.
PDCE
| $1.62M | ﹤0.01% |
54,565
-636
| -1% | -$25.5K |
|
1496
Monro
MNRO
$398M
| $1.62M | ﹤0.01% |
23,568
+2,859
| +14% | +$209K |
|
1497
State Street Utilities Select Sector SPDR ETF
XLU
$22.5B
| $1.61M | ﹤0.01% |
60,874
-2,628
| -4% | -$71.4K |
|
1498
J&J Snack Foods
JJSF
$1.71B
| $1.59M | ﹤0.01% |
11,022
+974
| +10% | +$148K |
|
1499
Hain Celestial
HAIN
$53.7M
| $1.59M | ﹤0.01% |
100,449
+3,989
| +4% | +$88.8K |
|
1500
B&G Foods
BGS
$286M
| $1.59M | ﹤0.01% |
54,877
+1,905
| +4% | +$54.5K |
|
Similar funds
UBS AM's Q4 2018 Portfolio in Review
As of Q4 2018, UBS AM held 2,899 positions worth $116B, down 14% from $135B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
UBS AM's Q4 2018 filing shows 140 new, 1,359 increased, 845 reduced and 130 closed positions. Its largest new stake was Linde: 1,823,057 shares worth $284M. The largest sale was Aetna Inc, an estimated $339M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q4 2018 buy was Linde: 1,823,057 shares worth $284M.
- UBS AM added most to iShares US Treasury Bond ETF in Q4 2018, an estimated $215M increase.
- UBS AM's biggest Q4 2018 reduction was Meta Platforms (Facebook), cutting an estimated $182M.
- UBS AM fully exited Aetna Inc in Q4 2018, selling an estimated $339M.
- UBS AM's ten largest holdings make up 17% of its $116B portfolio in Q4 2018.
- UBS AM opened 140 new positions and closed 130 in Q4 2018.
- UBS AM's portfolio value fell 14% quarter-over-quarter to $116B.
Based on UBS AM's 13F filing for Q4 2018, filed 13 Feb 2019.